Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 138 Records) |
Query Trace: Lung Neoplasms and CYP1A1[original query] |
---|
Role of nicotine dependence on the relationship between variants in the nicotinic receptor genes and risk of lung adenocarcinoma. PloS one 2014 9 (9): e107268. Tseng Tung-Sung, Park Jong Y, Zabaleta Jovanny, Moody-Thomas Sarah, Sothern Melinda S, Chen Ted, Evans David E, Lin Hui- |
Susceptibility of lung cancer with polymorphisms of CYP1A1, GSTM1, GSTM3, GSTT1 and GSTP1 genotypes in the population of Inner Mongolia region. Asian Pacific journal of cancer prevention : APJCP 2014 15 (13): 5207-14. Jiang Xue-Yan, Chang Fu-Hou, Bai Tu-Ya, Lv Xiao-Li, Wang Min-J |
[Association of CYP1A1 Ile462Val polymorphisms with susceptibility to small cell lung cancer]. Wei sheng yan jiu = Journal of hygiene research 2014 May 43 (3): 393-6, 418. He Bing, Lin Jia, Cao Lei, Wang Hongge, Rao Juan, Liu Yingwen, Zhang Z |
Combined effects of CYP1A1 MspI and GSTM1 genetic polymorphisms on risk of lung cancer: an updated meta-analysis. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Sep 35 (9): 9281-90. Li Wen, Song Li-Qiang, Tan Ji |
CYP1A1 gene polymorphisms and smoking status as modifier factors for lung cancer risk. Gene 2014 May 541 (1): 26-30. Hussein Atef G, Pasha Heba F, El-Shahat Hanan M, Gad Doaa M, Toam Mostafa |
Association between the CYP1A1 T3801C polymorphism and risk of cancer: evidence from 268 case-control studies. Gene 2014 Jan 534 (2): 324-44. He Xiao-Feng, Wei Wu, Liu Zhi-Zhong, Shen Xu-Liang, Yang Xian-Bin, Wang Su-Lan, Xie Dao-L |
Lung cancer risk and genetic variants in East Asians: a meta-analysis. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Jun 35 (6): 5173-9. Zhang Qu, Jin Hong, Wang Lin, Xin BoBo, Zhang Jie, Zhou Yi, Sheng Sito |
Genetic polymorphisms of phase I and phase II metabolic enzymes as modulators of lung cancer susceptibility. Journal of cancer research and clinical oncology 2015 May 141 (5): 851-60. Mota P, Silva H C, Soares M J, Pego A, Loureiro M, Cordeiro C Robalo, Regateiro F |
CYP1A1 Ile462Val polymorphism and the risk of non-small cell lung cancer in a Chinese population. Tumori 0 100 (5): 547-52. Lin Jia, He Bing, Cao Lei, Zhang Zhi, Liu Hongmei, Rao Juan, Liu Yingwen, Shao Shasha, Wang Guangxia, Zhang Xuem |
MspI and Ile462Val polymorphisms in CYP1A1 and overall cancer risk: a meta-analysis. PloS one 2013 8 (12): e85166. Wu Bin, Liu Kang, Huang Huaxing, Yuan Jun, Yuan Wanqing, Wang Shangqian, Chen Tingting, Zhao Hu, Yin Changj |
Role of Metabolic Enzymes P450 (CYP) on Activating Procarcinogen and their Polymorphisms on the Risk of Cancers. Current drug metabolism 2015 16 (10): 850-63. He Xin, Feng Sh |
Association of CYP1A1, GSTM1 and GSTT1 gene polymorphisms with risk of non-small cell lung cancer in Andhra Pradesh region of South India. European journal of medical research 2016 21 (1): 17. Peddireddy Vidyullatha, Badabagni Siva Prasad, Gundimeda Sandhya Devi, Mamidipudi Vasudha, Penagaluru Pardhanandana Reddy, Mundluru Hema Pras |
Combinations of the Variant Genotypes of CYP1A1, GSTM1 and GSTT1 are Associated with an Increased Lung Cancer Risk in North Indian Population: a Case-Control Study. Pathology oncology research : POR 2016 Apr . Girdhar Yashila, Singh Navneet, Behera Digambar, Sharma Siddhar |
The interaction between smoking and CYP1A1 MspI polymorphism on lung cancer: a meta-analysis in the Chinese population. European journal of cancer care 2016 Feb . Zhang L-P, Wang C-P, Li L-H, Tang Y-F, Li W |
Correlation between gene polymorphisms of CYP1A1, GSTP1, ERCC2, XRCC1, and XRCC3 and susceptibility to lung cancer. Genetics and molecular research : GMR 2016 Nov 15 (4): . Liu H X, Li J, Ye B |
Synergistic association of CYP1A1 polymorphisms with increased susceptibility to squamous cell lung cancer in north Indian smokers. The International journal of biological markers 2016 Jul 0. Girdhar Yashila, Singh Navneet, Behera Digambar, Sharma Siddhar |
Interaction of the CYP1A1 gene polymorphism and smoking in non-small cell lung cancer susceptibility. Genetics and molecular research : GMR 2016 14 (4): 19411-7. Xie Y Q, Chen J M, Liu |
Xenobiotic/drug metabolizing enzyme and TP53 polymorphisms and clinical outcome in advanced nonsmall cell lung cancer patients. Turkish journal of medical sciences 2017 Apr 47 (2): 554-562. Karacao?lan Volkan, Ada Ahmet O?uz, Bilgen Serdar, Çetinkaya Guzide Tu?ba, Soyda? Emre, Kunak Celalettin Semih, Alpar Sibel Meryem, Gülhan Meral, I?can Mümt |
Development of diagnostic model of lung cancer based on multiple tumor markers and data mining. Oncotarget 2017 12 8 (55): 94793-94804. Wang Zhaoxian, Feng Feifei, Zhou Xiaoshan, Duan Liju, Wang Jing, Wu Yongjun, Wang |
Association of 12 polymorphic variants conferring genetic risk to lung cancer in Indian population: An extensive meta-analysis. Environmental and molecular mutagenesis 2017 Oct . Sengupta Debmalya, Guha Udayan, Bhattacharjee Samsiddhi, Sengupta Main |
Genetic polymorphisms of human cytochrome P450 CYP1A1 in an Egyptian population and tobacco-induced lung cancer. Genes and environment : the official journal of the Japanese Environmental Mutagen Society 2017 39 7. Ezzeldin Nada, El-Lebedy Dalia, Darwish Amira, El-Bastawisy Ahmed, Hassan Mirhane, Abd El-Aziz Shereen, Abdel-Hamid Mohamed, Saad-Hussein Am |
Role of Sequence Variations in AhR Gene Towards Modulating Smoking Induced Lung Cancer Susceptibility in North Indian Population: A Multiple Interaction Analysis. Current genomics 2018 May 19 (4): 313-326. Budhwar Sneha, Bahl Charu, Sharma Siddharth, Singh Navneet, Behera Digamb |
Interactive potential of genetic polymorphism in Xenobiotic metabolising and DNA repair genes for predicting lung cancer predisposition and overall survival in North Indians. Mutation research. Genetic toxicology and environmental mutagenesis 2018 Feb 826 15-24. Bhardwaj Apurva, Bahl Charu, Sharma Siddharth, Singh Navneet, Behera Digamb |
Population Pharmacokinetics and Adverse Events of Erlotinib in Japanese Patients with Non-small-cell Lung Cancer: Impact of Genetic Polymorphisms in Metabolizing Enzymes and Transporters. Biological & pharmaceutical bulletin 2018 41 (1): 47-56. Endo-Tsukude Chihiro, Sasaki Ji-Ichiro, Saeki Sho, Iwamoto Norihiro, Inaba Megumi, Ushijima Sunao, Kishi Hiroto, Fujii Shinji, Semba Hiroshi, Kashiwabara Kosuke, Tsubata Yukari, Hayashi Mitsuhiro, Kai Yuki, Saito Hideyuki, Isobe Takeshi, Kohrogi Hirotsugu, Hamada Akino |
Association between the combined effects of GSTM1 present/null and CYP1A1 MspI polymorphisms with lung cancer risk: an updated meta-analysis. Bioscience reports 2020 Sep . Zhang Wen-Ping, He Xiao-Feng, Ye Xiang-H |
The correlation of combined OGG1, CYP1A1 and GSTP1 gene variants and risk of lung cancer of male Iraqi waterpipe tobacco smokers. Molecular biology reports 2020 6 47 (7): 5155-5163. Kudhair Bassam K, Alabid Noralhuda N, Zayed Karrar S, Lafta Inam J, Taheri-Kafrani Asgh |
Polymorphisms of Drug-Metabolizing Enzymes and Transporters Contribute to the Individual Variations of Erlotinib Steady State Trough Concentration, Treatment Outcomes, and Adverse Reactions in Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer Patients. Frontiers in pharmacology 2020 11 664. Liao Dehua, Liu Zhigang, Zhang Yongchang, Liu Ni, Yao Dunwu, Cao Lizhi, Chen Yun, Fu Yilan, Yang Nong, Xiang Daxio |
Cytochrome P-450 Polymorphisms and Clinical Outcome in Patients with Non-Small Cell Lung Cancer. Turkish journal of pharmaceutical sciences 2020 5 14 (3): 319-323. I?can Mümtaz, Ada Ahmet O? |
A comprehensive meta-analysis and a case-control study give insights into genetic susceptibility of lung cancer and subgroups. Scientific reports 2021 Jul 11 (1): 14572. Sengupta Debmalya, Banerjee Souradeep, Mukhopadhyay Pramiti, Mitra Ritabrata, Chaudhuri Tamohan, Sarkar Abhijit, Bhattacharjee Gautam, Nath Somsubhra, Roychoudhury Susanta, Bhattacharjee Samsiddhi, Sengupta Main |
Genetic Analysis of Lung Cancer and the Germline Impact on Somatic Mutation Burden. Journal of the National Cancer Institute 2022 May . Gabriel Aurélie A G, Atkins Joshua R, Penha Ricardo C C, Smith-Byrne Karl, Gaborieau Valerie, Voegele Catherine, Abedi-Ardekani Behnoush, Milojevic Maja, Olaso Robert, Meyer Vincent, Boland Anne, Deleuze Jean François, Zaridze David, Mukeriya Anush, Swiatkowska Beata, Janout Vladimir, Schejbalová Miriam, Mates Dana, Stojši? Jelena, Ognjanovic Miodrag, , Witte John S, Rashkin Sara R, Kachuri Linda, Hung Rayjean J, Kar Siddhartha, Brennan Paul, Sertier Anne-Sophie, Ferrari Anthony, Viari Alain, Johansson Mattias, Amos Christopher I, Foll Matthieu, McKay James |
- Page last reviewed:Feb 1, 2024
- Content source: